Sort
38,696 grants matching “als”
Investigating Informal Caregivers' Involvement in End-of-Life Care among Assisted Living Residents with Advanced Dementia and its Influence on Resident and Caregiver Outcomes
$706,597Molly M Perkins · Emory University · R01 · FY2025 · AG
Carbohydrate Antigen-bearing Nanoparticles for Antitumor Therapy
$706,429Joseph John Barchi · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Feasibility of a music listening intervention for mental health recovery in chronic stroke
$706,367Pablo Ripolles · New York University · R34 · FY2024 · AT
Role of Immune and Inflammation Mediators in Progression of Pancreatic Cancer
$706,297Syed Hussain · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Integrative Molecular Profiling of Human Pancreatic Cancer
$706,297Syed Hussain · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
SCB Structural Cell Biology Core
$706,111John A Tainer · University Of Calif-Lawrenc Berkeley Lab · P01 · FY2015 · CA
Molecular effects of metformin, PKR and TBI on C9orf72 ALS/FTD
$705,919Laura Pw Ranum · University Of Florida · R01 · FY2025 · NS
Molecular Characterization of ALS/FTD in a novel C9orf72 BAC mouse model.
$705,907Laura Pw Ranum · University Of Florida · R01 · FY2019 · NS
Understanding Emerging artemisinin partner drug resistance in eastern Africa
$705,896Michael T Ferdig · University Of Notre Dame · R01 · FY2025 · AI
Nuclear import receptors as modifiers of TDP-43 phase transition and toxicity in FTD/ALS
$705,885Wilfried Rossoll · Mayo Clinic Jacksonville · R01 · FY2025 · AG
Novel sanitizer/disinfectants against viral infections with long-lasting effect
$705,771Stephen Hsu · Camellix, Llc · R42 · FY2019 · AI
Role of Immune and Inflammation Mediators in Progression of Pancreatic Cancer
$705,721Syed Perwez Hussain · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Integrative Molecular Profiling of Human Pancreatic Cancer
$705,721Syed Perwez Hussain · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Linkage Disequilibrium Studies of Alcohol Dependence
$705,574Joel Gelernter · Yale University · R01 · FY2006 · AA
Services Research: Psychiatric Comorbidity in Drug Abuse
$705,493Robert K Brooner · Johns Hopkins University · R01 · FY2007 · DA
A Multidimensional Community-Based Strategy for Preventing Underage Drinking
$705,475Anthony Biglan · Oregon Research Institute · R01 · FY2014 · AA
Targeting GPCRs in amygdalar and cortical neural ensembles to treat pain aversion
$705,382Gregory Scherrer · Univ Of North Carolina Chapel Hill · R01 · FY2024 · NS
Optimizing oscillatory epidural electrical stimulation to selectively increase task-related population dynamics in motor areas
$705,175Karunesh Ganguly · University Of California, San Francisco · R01 · FY2023 · NS
Immune reconstitution following autologous and allogeneic stem cell transplant
$705,120Frances Hakim · Division Of Basic Sciences - Nci · ZIC · FY2015 · CA
Genetic Linkage Study in Parkinson's Disease
$705,116Boston University Medical Campus · R01 · FY2005 · NS
Caloric Restriction, Environment, and Fitness: Reproductive Effects Evaluation Study (CaREFREE Study)
$705,055Janet Hall · National Institute Of Environmental Health Sciences · ZIA · FY2018 · ES
Identification of HIV latency biomarkers with a dual fluorescence reporter HIV
$705,007Eric M Verdin · J. David Gladstone Institutes · R01 · FY2015 · AI
Prevention of OUD: The HOME (Housing, Opportunities, Motivation and Engagement) Randomized Trial
$704,941Natasha Slesnick · Ohio State University · UG3 · FY2019 · DA
ECONOMIC COST OF DRUG USE AND ABUSE
$704,854Rosalie Pacula · Rand Corporation · R01 · FY2006 · DA
A Phase III Randomized Trial Comparing Unrelated Donor Bone Marrow Transplantation with Immune Suppressive Therapy for Newly Diagnosed Pediatric and Young Adult Patients with Severe Aplastic Anemia
$704,843David A Williams · Boston Children'S Hospital · UH3 · FY2023 · HL